Foxiga Korea Local Phase 4 Study

Exclusion Criteria

• •1. Type 1 diabetes or history of diabetic ketoacidosis
• •2. Pregnant or breast-feeding patients
• •3. eGFR \< 60 mL/min/1.73 m2 (MDRD) on visit 1.
• •4. Indication of active liver disease (AST/ALT/total bilirubin \> 3 X upper limits of normal) on visit 1.
• •5. Acute coronary syndrome, stroke or TIA within 3 months prior to randomization
• •6. Bariatric surgery within 2 years; treatment of anti-obesity drugs 3 months prior to randomization; any treatment leading to unstable body weight. (Unstable body weight is considered reliable in the judgment of the Investigator.)
• •7. History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis at any time
• •8. History of any other malignancy within 5 years (with the exception of successfully treated non-melanoma skin cancers)
• •9. History of alcohol or drug abuse judged by physician within 3 months prior to randomization
• •10. Concomitant participation in any other clinical study.